首页   >  
GPCR/G Protein
  >  
CXCR

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

CXCR

结构式 货号 产品名称 CAS号
ACT-1004-1239 结构式
BCP46165 ACT-1004-1239 2178049-58-4
ACT-1004-1239 is a potent, insurmountable antagonist.
ML339 结构式
BCP45761 ML339 2579689-83-9
ML-339 is a potent and selective hCXCR6 antagonist (IC50 = 140 nM).
ML 145 结构式
BCP45167 ML 145 1164500-72-4
ML 145 is a selective antagonist for the GPR35 orphan receptor GPCR (IC50 = 20.1 nM). Over 1000-fold more selective for GPR35 compared to GPR55 antagonists.
VUF11418 结构式
BCP37842 VUF11418 1414376-85-4
VUF11418 first reported nonpeptidomimetic agonist on The G protein-coupled chemokine receptor CXCR3.
VUF11207 fumarate 结构式
BCP34887 VUF11207 fumarate 1785665-61-3
VUF11207 fumarate is a CXCR7 agonist and a high-potency CXCR7 (pKi of 8.1) ligand that induces recruitment of β-arrestin2 (pEC50 of 8.8) and subsequent internalization (pEC50 of 7.9) of CXCR7.
ALX 40-4C 结构式
BCP34188 ALX 40-4C 143413-49-4
ALX 40-4C is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1; ALX 40-4C Trifluoroacetate also acts as an antagonist of the APJ receptor, with an IC50 of 2.9 μM.
NBI-74330 结构式
BCP34091 NBI-74330 855527-92-3
NBI-74330 is a small molecule antagonist for CXCR3
USL311 结构式
BCP33234 USL311 1373268-67-7
USL311 is a selective CXCR4 antagonist, with anti-tumor activity. USL311 prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.
Mavorixafor trihydrochloride 结构式
BCP26048 Mavorixafor trihydrochloride 880549-30-4
Mavorixafor is a potent, selective and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 and 9 nM, respectively.
BX471 hydrochloride 结构式
BCP32594 BX471 hydrochloride 288262-96-4
BX471 hydrochloride is a potent, selective non-peptide CCR1 antagonist with Ki of 1 nM for human CCR1, and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
123下一页末页共 39 条记录 1 / 4 页 
2853530911